Patients with implantable cardioverter defibrillators (ICD) often suff
er inappropriate ICD-therapies. The incidence, causes and risk factors
of ICD-therapies for a rhythm other than ventricular tachyarrhythmias
(VT) were determined retrospectively in 462 consecutive patients (pts
). Inappropriate ICD-therapies were identified based on stored R-R int
ervals and/or electrograms. Eighty-two pts (18%) had inappropriate ICD
-therapies. Actuarial rates for inappropriate ICD-therapies were 13%,
20%, 24% and 29% at 1, 2, 3 and 4 years after ICD-implantation, respec
tively. Atrial fibrillation with rapid ventricular response was the mo
st common cause (34 pts, 39%). In 26 pts (30%), sinus tachycardia trig
gered inappropriate ICD-therapies, in 21 pts (24%) oversensing, mostly
due to fractures and insulation failures of the leads, in three pts a
trial flutter, in two pts non-sustained VT, in one pt supraventricular
tachycardia and in another pt T-wave double sensing caused inappropri
ate ICD-therapies. In order to prevent recurrences of inappropriate IC
D-therapies due to atrial fibrillation or sinus tachycardia, a rate st
ability (n = 19) or onset (n = 15) criterion was programmed, 41 pts ad
ditionally received betablocking agents and/or digoxin. In pts with ov
ersensing an operative revision of lead system was performed. During f
urther follow-up (15 +/- 13 months), 15 pts had recurrences of inappro
priate ICD-therapies (eight pts due to atrial fibrillation, three due
to sinus tachycardia and four due to oversensing). On multivariate ana
lysis (Cox regression), history of atrial fibrillation, maximum heart
rate during exercise and low cut-off rate for VT-detection were predic
tors of inappropriate ICD-therapies. Thus, inappropriate ICD-therapies
are frequent, especially in the first year after implantation. Additi
onal detection criteria, betablocking agents and/or digoxin prevent re
currences in most patients. In patients with a history of atrial fibri
llation, high heart rate during exercise or a low cut-off rate for VT-
detection, activation of additional detection criteria should be consi
dered directly after ICD-implantation.